Correlation Between Puma Biotechnology and AN2 Therapeutics
Can any of the company-specific risk be diversified away by investing in both Puma Biotechnology and AN2 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Puma Biotechnology and AN2 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Puma Biotechnology and AN2 Therapeutics, you can compare the effects of market volatilities on Puma Biotechnology and AN2 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Puma Biotechnology with a short position of AN2 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Puma Biotechnology and AN2 Therapeutics.
Diversification Opportunities for Puma Biotechnology and AN2 Therapeutics
0.65 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Puma and AN2 is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Puma Biotechnology and AN2 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AN2 Therapeutics and Puma Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Puma Biotechnology are associated (or correlated) with AN2 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AN2 Therapeutics has no effect on the direction of Puma Biotechnology i.e., Puma Biotechnology and AN2 Therapeutics go up and down completely randomly.
Pair Corralation between Puma Biotechnology and AN2 Therapeutics
Given the investment horizon of 90 days Puma Biotechnology is expected to generate 0.65 times more return on investment than AN2 Therapeutics. However, Puma Biotechnology is 1.54 times less risky than AN2 Therapeutics. It trades about 0.0 of its potential returns per unit of risk. AN2 Therapeutics is currently generating about -0.08 per unit of risk. If you would invest 400.00 in Puma Biotechnology on September 14, 2024 and sell it today you would lose (115.00) from holding Puma Biotechnology or give up 28.75% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Puma Biotechnology vs. AN2 Therapeutics
Performance |
| Timeline |
| Puma Biotechnology |
| AN2 Therapeutics |
Puma Biotechnology and AN2 Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Puma Biotechnology and AN2 Therapeutics
The main advantage of trading using opposite Puma Biotechnology and AN2 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Puma Biotechnology position performs unexpectedly, AN2 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AN2 Therapeutics will offset losses from the drop in AN2 Therapeutics' long position.| Puma Biotechnology vs. Ultragenyx | Puma Biotechnology vs. Crinetics Pharmaceuticals | Puma Biotechnology vs. Arvinas | Puma Biotechnology vs. Revolution Medicines |
| AN2 Therapeutics vs. Puma Biotechnology | AN2 Therapeutics vs. Iovance Biotherapeutics | AN2 Therapeutics vs. Day One Biopharmaceuticals | AN2 Therapeutics vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |